Literature DB >> 27234232

Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression.

Vince Kornél Grolmusz1,2, Eszter Angéla Tóth3, Kornélia Baghy4, István Likó2,5, Ottó Darvasi2,5, Ilona Kovalszky4, János Matkó3, Károly Rácz1,5, Attila Patócs6,7,8.   

Abstract

BACKGROUND: Previously, drug-based synchronization procedures were used for characterizing the cell cycle dependent transcriptional program. However, these synchronization methods result in growth imbalance and alteration of the cell cycle machinery. DNA content-based fluorescence activated cell sorting (FACS) is able to sort the different cell cycle phases without perturbing the cell cycle. MiRNAs are key transcriptional regulators of the cell cycle, however, their expression dynamics during cell cycle has not been explored.
METHODS: Following an optimized FACS, a complex initiative of high throughput platforms (microarray, Taqman Low Density Array, small RNA sequencing) were performed to study gene and miRNA expression profiles of cell cycle sorted human cells originating from different tissues. Validation of high throughput data was performed using quantitative real time PCR. Protein expression was detected by Western blot. Complex statistics and pathway analysis were also applied.
RESULTS: Beyond confirming the previously described cell cycle transcriptional program, cell cycle dependently expressed genes showed a higher expression independently from the cell cycle phase and a lower amplitude of dynamic changes in cancer cells as compared to untransformed fibroblasts. Contrary to mRNA changes, miRNA expression was stable throughout the cell cycle.
CONCLUSIONS: Cell cycle sorting is a synchronization-free method for the proper analysis of cell cycle dynamics. Altered dynamic expression of universal cell cycle genes in cancer cells reflects the transformed cell cycle machinery. Stable miRNA expression during cell cycle progression may suggest that dynamical miRNA-dependent regulation may be of less importance in short term regulations during the cell cycle.

Entities:  

Keywords:  Cell cycle; DNA staining; Dynamic expression; Fluorescence-activated cell sorting (FACS); miRNA

Mesh:

Substances:

Year:  2016        PMID: 27234232      PMCID: PMC4884355          DOI: 10.1186/s12864-016-2747-6

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  55 in total

Review 1.  Classic "broken cell" techniques and newer live cell methods for cell cycle assessment.

Authors:  Lindsay Henderson; Dante S Bortone; Curtis Lim; Alexander C Zambon
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

2.  Robust global microRNA expression profiling using next-generation sequencing technologies.

Authors:  Shirley Tam; Richard de Borja; Ming-Sound Tsao; John D McPherson
Journal:  Lab Invest       Date:  2014-01-20       Impact factor: 5.662

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.

Authors:  Henriett Butz; István Likó; Sándor Czirják; Péter Igaz; Mohammed Munayem Khan; Vladimir Zivkovic; Katalin Bálint; Márta Korbonits; Károly Rácz; Attila Patócs
Journal:  J Clin Endocrinol Metab       Date:  2010-07-28       Impact factor: 5.958

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Deregulated expression of miR-106a predicts survival in human colon cancer patients.

Authors:  Raquel Díaz; Javier Silva; José M García; Yolanda Lorenzo; Vanesa García; Cristina Peña; Rufo Rodríguez; Concepción Muñoz; Fernando García; Félix Bonilla; Gemma Domínguez
Journal:  Genes Chromosomes Cancer       Date:  2008-09       Impact factor: 5.006

8.  Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication.

Authors:  J Gong; F Traganos; Z Darzynkiewicz
Journal:  Cell Growth Differ       Date:  1995-11

9.  A signature-based method for indexing cell cycle phase distribution from microarray profiles.

Authors:  Hideaki Mizuno; Yoshito Nakanishi; Nobuya Ishii; Akinori Sarai; Kunio Kitada
Journal:  BMC Genomics       Date:  2009-03-30       Impact factor: 3.969

10.  Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control.

Authors:  Peng Dong; Manoj V Maddali; Jaydeep K Srimani; François Thélot; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Nat Commun       Date:  2014-09-01       Impact factor: 14.919

View more
  4 in total

1.  MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.

Authors:  Vince Kornél Grolmusz; Katalin Borka; Annamária Kövesdi; Kinga Németh; Katalin Balogh; Csaba Dékány; András Kiss; Anna Szentpéteri; Beatrix Sármán; Anikó Somogyi; Éva Csajbók; Zsuzsanna Valkusz; Miklós Tóth; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Virchows Arch       Date:  2017-06-08       Impact factor: 4.064

2.  Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.

Authors:  Vince Kornél Grolmusz; Katalin Karászi; Tamás Micsik; Eszter Angéla Tóth; Katalin Mészáros; Gellért Karvaly; Gábor Barna; Péter Márton Szabó; Kornélia Baghy; János Matkó; Ilona Kovalszky; Miklós Tóth; Károly Rácz; Péter Igaz; Attila Patócs
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

3.  Discovering the 3' UTR-mediated regulation of alpha-synuclein.

Authors:  Domenica Marchese; Teresa Botta-Orfila; Davide Cirillo; Juan Antonio Rodriguez; Carmen Maria Livi; Rubén Fernández-Santiago; Mario Ezquerra; Maria J Martí; Elias Bechara; Gian Gaetano Tartaglia
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

4.  Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model.

Authors:  Vince Kornél Grolmusz; Jinfeng Chen; Rena Emond; Patrick A Cosgrove; Lance Pflieger; Aritro Nath; Philip J Moos; Andrea H Bild
Journal:  Cancer Cell Int       Date:  2020-06-17       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.